The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Outpatient Oncology Infusion Market Expected To Reach Based On Its 2026 Value?
The market size for outpatient oncology infusion has experienced robust growth in recent years. It is projected to expand from $14.02 billion in 2025 to $15.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. Historically, this growth has been driven by factors such as rising cancer prevalence rates, the expansion of outpatient oncology infrastructure, the uptake of infusion-based therapies, enhanced survival rates necessitating continuous treatment, and the presence of sophisticated infusion devices.
The outpatient oncology infusion market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $20.21 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.5%. This growth over the forecast period is attributable to the increasing demand for precision oncology treatments, rising investments in outpatient infusion centers, the expansion of home-compatible infusion technologies, a growing focus on cost-efficient cancer care, and the increasing integration of digital oncology monitoring. Significant trends for the forecast period include a growing shift toward outpatient cancer treatment models, the rising adoption of targeted and immunotherapies, the increasing use of smart infusion pumps, the expansion of ambulatory infusion centers, and an enhanced focus on patient-centric oncology care.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp
Which Primary Drivers Are Impacting The Outpatient Oncology Infusion Market Growth?
The rising occurrence of cancer cases is anticipated to propel the expansion of the outpatient oncology infusion market in the future. Cancer refers to a collection of intricate illnesses characterized by the unchecked proliferation of anomalous cells, which are capable of invading nearby tissues and disseminating throughout the body. The growing incidence of cancer is largely attributed to the global aging demographic, given that the likelihood of developing cancer substantially increases with age. Outpatient oncology infusion provides a method for delivering cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical environment without requiring hospital admission, allowing patients to receive care while continuing their daily routines. For instance, in April 2024, according to Macmillan Cancer Support, a UK-based charity providing practical, emotional, and financial support to people affected by cancer, it is projected that the number of individuals living with cancer in the UK will exceed 3 million presently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the expanding occurrence of cancer cases is driving the growth of the outpatient oncology infusion market.
How Are Different Segments Classified In The Outpatient Oncology Infusion Market Segment Analysis?
The outpatient oncology infusion market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors
Which Trends Are Shaping Growth In The Outpatient Oncology Infusion Market?
Major companies operating in the outpatient oncology infusion market are significantly investing in technological upgrades for infusion systems, specifically next-generation smart infusion pumps, to elevate medication safety and optimize chemotherapy delivery. These modern smart infusion pumps represent digitally connected devices that incorporate advanced dose-error reduction software, integrated drug libraries, and real-time connectivity, all aimed at minimizing errors and standardizing oncology treatments. For instance, in April 2024, Baxter International Inc., a US-based medical technology company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large-volume infusion pump, thereby making it accessible for U.S. ordering. This integrated hardware-software system delivers precise large-volume infusions, complete with embedded safety checks, dose-library enforcement, and connectivity for remote management. Baxter highlights its advanced safety architecture, enhanced usability, and compatibility within its wider infusion ecosystem. The pump is well-suited for outpatient oncology infusion centers, ambulatory clinics, and hospitals, providing advantages such as superior dosing accuracy, more efficient nursing workflows, and fewer delays or negative incidents during chemotherapy administration.
Who Are The Companies Driving Activity In The Outpatient Oncology Infusion Market?
Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.
Get The Full Outpatient Oncology Infusion Market Report:
https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report
Which Region Represents The Largest Share Of The Outpatient Oncology Infusion Market?
North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Outpatient Oncology Infusion Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report
Browse Through More Reports Similar to the Global Outpatient Oncology Infusion Market 2026, By The Business Research Company
Home Infusion Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report
Home Healthcare Market Report
https://www.thebusinessresearchcompany.com/report/home-healthcare-global-market-report
Online Therapy Services Market Report
https://www.thebusinessresearchcompany.com/report/online-therapy-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model